Works matching DE "RIFAXIMIN"
Results: 147
Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 373, doi. 10.1007/s40267-023-01027-8
- By:
- Publication type:
- Article
Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 3, p. 313, doi. 10.1159/000518067
- By:
- Publication type:
- Article
The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
Diverticular Disease and Rifaximin: An Evidence-Based Review.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 443, doi. 10.3390/antibiotics12030443
- By:
- Publication type:
- Article
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 12, p. 1680, doi. 10.3390/antibiotics11121680
- By:
- Publication type:
- Article
NiFe<sub>2</sub>O<sub>4</sub>/GO Nanocomposite as an Effective Adsorbent for Modelling Removal of Rifaximin from Pharmaceutical Wastewater Using Box–Behnken Response Surface Methodology.
- Published in:
- Russian Journal of General Chemistry, 2023, v. 93, p. S934, doi. 10.1134/S1070363223170103
- By:
- Publication type:
- Article
利福昔明在肝硬化相关并发症中的应用.
- Published in:
- Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2018, v. 34, n. 7, p. 1551, doi. 10.3969/j.issn.1001-5256.2018.07.040
- By:
- Publication type:
- Article
Volatile cinnamaldehyde induces systemic salt tolerance in the roots of rice (Oryza sativa).
- Published in:
- Physiologia Plantarum, 2023, v. 175, n. 3, p. 1, doi. 10.1111/ppl.13938
- By:
- Publication type:
- Article
Mean Blood Ammonia Level After Treatment With Rifaximin Versus Neomycin In Chronic Liver Disease Patients Presenting With Hepatic Encephalopathy.
- Published in:
- Annals of King Edward Medical University, 2019, v. 25, n. 1, p. 1
- By:
- Publication type:
- Article
Preparation of S-Scheme g-C 3 N 4 /ZnO Heterojunction Composite for Highly Efficient Photocatalytic Destruction of Refractory Organic Pollutant.
- Published in:
- Catalysts (2073-4344), 2023, v. 13, n. 3, p. 485, doi. 10.3390/catal13030485
- By:
- Publication type:
- Article
Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial.
- Published in:
- Journal of Neurogastroenterology & Motility, 2024, v. 30, n. 2, p. 220, doi. 10.5056/jnm23029
- By:
- Publication type:
- Article
Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats.
- Published in:
- Journal of Neurogastroenterology & Motility, 2023, v. 29, n. 4, p. 520, doi. 10.5056/jnm22182
- By:
- Publication type:
- Article
Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat.
- Published in:
- Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/4078681
- By:
- Publication type:
- Article
Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14727, doi. 10.3390/ijms241914727
- By:
- Publication type:
- Article
Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7383, doi. 10.3390/ijms23137383
- By:
- Publication type:
- Article
Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 5064, doi. 10.3390/ijms23095064
- By:
- Publication type:
- Article
Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis.
- Published in:
- BMC Gastroenterology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12876-024-03184-0
- By:
- Publication type:
- Article
Adherence to rifaximin initiation and prescribing within King's College Hospital and transfer of prescribing to primary care.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Gastrointestinal Involvement in Systemic Sclerosis - Review of 250 Patients' Clinical, Radiological and Serological Profile - A Retrospective Study.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1358, doi. 10.3390/jcm14041358
- By:
- Publication type:
- Article
A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6948, doi. 10.3390/jcm13226948
- By:
- Publication type:
- Article
The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 166, doi. 10.3390/jcm13010166
- By:
- Publication type:
- Article
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 14, doi. 10.3390/jcm13010014
- By:
- Publication type:
- Article
Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6871, doi. 10.3390/jcm12216871
- By:
- Publication type:
- Article
Rifaximin Use, Adherence and Persistence in Patients with Hepatic Encephalopathy: A Real-World Study in the South of Italy.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4515, doi. 10.3390/jcm12134515
- By:
- Publication type:
- Article
Severe Ulcerative Colitis Complicated by Malakoplakia Resulting in Proctocolectomy.
- Published in:
- ACG Case Reports Journal, 2024, v. 11, n. 1, p. 1, doi. 10.14309/crj.0000000000001257
- By:
- Publication type:
- Article
Role of non-absorbable oral antibiotics in bowel preparation for intracavitary brachytherapy: effects of rifaximin on rectal dosimetric parameters during vaginal cuff brachytherapy.
- Published in:
- Journal of Contemporary Brachytherapy, 2021, v. 13, n. 4, p. 426, doi. 10.5114/jcb.2021.108597
- By:
- Publication type:
- Article
Irritable bowel syndrome in adolescents.
- Published in:
- Journal of Alternative Medicine Research, 2023, v. 15, n. 4, p. 407
- By:
- Publication type:
- Article
A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose.
- Published in:
- Asian Journal of Medical Sciences, 2021, v. 12, n. 3, p. 46, doi. 10.3126/ajms.v12i3.32808
- By:
- Publication type:
- Article
Eco-Friendly Pharmaceutical Analysis of Rifaximin in Tablets by HPLC-MS and Microbiological Turbidimetry.
- Published in:
- Journal of Chromatographic Science, 2021, v. 59, n. 7, p. 597, doi. 10.1093/chromsci/bmab044
- By:
- Publication type:
- Article
Rifaximin modulates TRH and TRH-like peptide expression throughout the brain and peripheral tissues of male rats.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice.
- Published in:
- BMC Microbiology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12866-023-02772-6
- By:
- Publication type:
- Article
Corrigendum to Prophylactic antibiotics in patients with alcohol‐associated hepatitis receiving steroids: A systematic review and meta‐analysis.
- Published in:
- 2024
- Publication type:
- Correction Notice
Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci.
- Published in:
- Liver International, 2023, v. 43, n. 9, p. 2039, doi. 10.1111/liv.15667
- By:
- Publication type:
- Article
Amalgam of ternary solid dispersion and P-gp efflux inhibition in development of colon-targeted tablets of rifaximin.
- Published in:
- Journal of Reports in Pharmaceutical Sciences, 2022, v. 11, n. 2, p. 222, doi. 10.4103/jrptps.JRPTPS_21_22
- By:
- Publication type:
- Article
An Effectiveness of Ayurveda Management in Crohn's Disease.
- Published in:
- Journal of Integrated Health Sciences, 2024, v. 12, n. 1, p. 80, doi. 10.4103/jihs.jihs_13_24
- By:
- Publication type:
- Article
On the Analytic Characteristics of Commercial Acetaminophen Assays in the United States<sup> </sup>.
- Published in:
- Journal of Applied Laboratory Medicine, 2022, v. 7, n. 6, p. 1311, doi. 10.1093/jalm/jfac059
- By:
- Publication type:
- Article
FORMULATION AND CHARACTERIZATION OF RIFAXIMIN COLON TARGETING NANOSPONGES.
- Published in:
- Biochemical & Cellular Archives, 2024, p. 3569, doi. 10.51470/bca.2024.24.1-S.3569
- By:
- Publication type:
- Article
Ziziphus spina-christi Leaf-Derived Carbon Dots as a Fluorescence Nanosensor to Evaluate Rifaximin Antibacterial via Inner Filter Effect: Greenness and Whiteness Studies.
- Published in:
- Chemosensors, 2023, v. 11, n. 5, p. 275, doi. 10.3390/chemosensors11050275
- By:
- Publication type:
- Article
Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1263, doi. 10.3390/biomedicines10061263
- By:
- Publication type:
- Article
Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.
- Published in:
- Biomedical Reports, 2025, v. 22, n. 1, p. N.PAG, doi. 10.3892/br.2024.1882
- By:
- Publication type:
- Article
Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1121435
- By:
- Publication type:
- Article
A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli.
- Published in:
- BMC Veterinary Research, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s12917-022-03564-2
- By:
- Publication type:
- Article
Comparison of Safety and Efficacy of Neomycin versus Rifaximin in Chronic Recurrent Hepatic Encephalopathy.
- Published in:
- QJM: An International Journal of Medicine, 2024, v. 117, p. ii156, doi. 10.1093/qjmed/hcae175.363
- By:
- Publication type:
- Article
A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 1996, doi. 10.1007/s10620-024-08445-2
- By:
- Publication type:
- Article
Italian guidelines for the management of irritable bowel syndrome in children and adolescents: Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM)
- Published in:
- Italian Journal of Pediatrics, 2024, v. 50, n. 1, p. 1, doi. 10.1186/s13052-024-01607-y
- By:
- Publication type:
- Article
Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat.
- Published in:
- Journal of Neuroinflammation, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12974-021-02303-y
- By:
- Publication type:
- Article
Clinical Transplant Kidney Function Loss Due to Small Intestinal Bacterial Overgrowth.
- Published in:
- Indian Journal of Nephrology, 2024, v. 34, n. 5, p. 526, doi. 10.25259/ijn_535_23
- By:
- Publication type:
- Article
利福昔明联合枯草杆菌二联活菌治疗 小肠细菌过度生长的研究.
- Published in:
- Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 14, p. 1815, doi. 10.3969/j.issn.1006-5725.2023.14.015
- By:
- Publication type:
- Article